vimarsana.com

Page 4 - மான்ட்ரியல் நரம்பியல் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Making progress to Strike Out ALS: Physician sees some promise in drug trials

Add the ALS Society of Quebec to the list of non-profit organizations thinking outside of the box during these COVID-19 times. ALS is a neurodegenerative incurable fatal illness that destroys motor neurons. People with ALS gradually lose their mobility, but also their ability to talk, eat and eventually, breathe. Senses are not affected and 80 percent die within two to five years after the diagnosis. There are currently more than 500 Quebecers living with ALS. It is known as Lou Gehrig’s disease after the baseball great who succumbed to ALS on June 2, 1941. For the past two years Major League Baseball has recognized this as “Lou Gehrig Day.” Locally, former Expos, sports, media (including me) and entertainment personalities have united to Strike out ALS. Everyone is invited to take part in this initiative by sharing their stories, pictures and a message of hope through an impressive mosaic. They can also honor someone who is living with ALS, or a lost a loved one and

ALS Biomarkers in Drug Development, Upcoming Webinar Hosted by Xtalks

ALS Biomarkers in Drug Development, Upcoming Webinar Hosted by Xtalks Share Article In this free webinar, industry experts will provide an overview of different types of ALS biomarkers, how ALS biomarkers should be chosen based on the relevance to the mechanism of action and why their use in ALS trials should be a serious consideration. They will also discuss how some biomarkers in ALS research are more valuable than others at this time, as well as the application of ALS biomarkers in drug development. There is a strong need for research, understanding and potential treatments in ALS. This webinar will focus on ALS biomarkers.

New study shows how our brains sync hearing with vision -- Science of the Spirit -- Sott net

Tue, 11 May 2021 18:32 UTC To make sense of complex environments, brain waves constantly adapt, compensating for drastically different sound and vision processing speeds © Montreal Neurological Institute-Hospital MEG signals revealed that recalibration was enabled by a unique interaction between fast and slow brain waves in auditory and visual brain regions.Every high-school physics student learns that sound and light travel at very different speeds. If the brain did not account for this difference, it would be much harder for us to tell where sounds came from, and how they are related to what we see. Instead, the brain allows us to make better sense of our world by playing tricks, so that a visual and a sound created at the same time are perceived as synchronous, even though they reach the brain and are processed by neural circuits at different speeds.

Sanofi hires AstraZeneca s corporate affairs chief for vaccine comms role

Pharma giant Sanofi Pasteur has poached Eleanor Duff from AstraZeneca to become its head of global comms. by Jonathan Owen Sign in to continue Register Limited Article Views (Excludes Subscriber Only Content) Select Newsletters (Excludes Subscriber Only Bulletins) Limited number of free email bulletins Unlimited Access to PRWeek content Daily Breakfast Briefing PRWeek Daily News (subscriber-exclusive email bulletin) Exclusive access to Power Book and Top 150 UK Consultancies/Agency Business Report content PRWeek magazine delivered

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.